By Josh White
Date: Thursday 26 Feb 2026
| Form 8.5 (EPT/NON-RI) Oxford Biomedica plc | 26-Feb-2026 | 09:42 | RNS |
| Form 8.5 (EPT/RI)-NCC Group plc | 26-Feb-2026 | 09:13 | GlobeNewswire NA |
| Linerixibat accepted for priority review in China | 26-Feb-2026 | 07:05 | RNS |
| Bepirovirsen accepted for Japan regulatory review | 26-Feb-2026 | 07:00 | RNS |
| Transaction in Own Shares | 26-Feb-2026 | 07:00 | RNS |
| Questor:Meggitt | 23-Dec-2014 | Telegraph |
| Questor :KCOM | 27-Nov-2014 | Telegraph |
| Questor :Ricardo | 31-Oct-2014 | Telegraph |
| Questor:CSR | 17-Oct-2014 | Telegraph |
| Questor:BAE Systems | 03-Sep-2014 | Telegraph |
| Price | 6,025.17 |
| Change Today | -18.24 |
| % Change | -0.30 % |
| 25-Feb-26 Close | 6,043.41 |
You are here: research